Hana Biosciences, Inc. (NASDAQ: HNAB) is a South San Francisco, CA-based biopharmaceutical company focused on acquiring, developing, and commercializing innovative products to strengthen the foundation of cancer care. The company is committed to creating value by building a best in-class team, accelerating the development of lead product candidates, expanding its pipeline by being an alliance partner of choice, and nurturing a unique company culture.

•  Corporate Presentation
•  2008 Annual Report

June 2, 2009
Hana Biosciences Presents Updated Marqibo Data At the American Society of Clinical Oncology Annual Meeting

May 15, 2009
Hana Biosciences Announces First Quarter 2009 Results